In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates

Molecular Pharmaceutics

Volumn 9, Issue 5, 2012, Pages 1136-1145

  Fani, Melpomeni ^a,b   Tamma, Maria Luisa ^a   Nicolas, Guillaume P ^a   Lasri, Elisabeth ^c   Medina, Christelle ^c   Raynal, Isabelle ^c   Port, Marc ^c   Weber, Wolfgang A ^b   Maecke, Helmut R ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Research Department   (France)

Author keywords

folate receptor; folic acid; gallium 68; NODAGA folate conjugates; PET imaging

Indexed keywords

1,4,7 TRIAZACYCLONONANE,1 GLUTARIC ACID 4,7 ACETIC ACID FOLIC ACID CONJUGATE GA 68; FOLATE RECEPTOR; FOLIC ACID; PEMETREXED; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIARY EXCRETION; BINDING AFFINITY; CELL STRAIN KB; CONJUGATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; KIDNEY; MOLECULAR IMAGING; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PLASMA CLEARANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIOACTIVITY; RECEPTOR BINDING; ROOM TEMPERATURE; SALIVARY GLAND; TUMOR SCINTISCANNING; TUMOR XENOGRAFT;

ACETATES; ANIMALS; CELL LINE, TUMOR; FEMALE; FOLATE RECEPTORS, GPI-ANCHORED; FOLIC ACID; GALLIUM RADIOISOTOPES; HETEROCYCLIC COMPOUNDS; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY;

EID: 84860705395     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200418f     Document Type: Article

References (38)

1. Stover, P. J. Physiology of folate and vitamin B12 in health and disease Nutr. Rev. 2004, 62, S3-12 discussion S13
2. Matherly, L. H.; Goldman, D. I. Membrane transport of folates Vitam. Horm. 2003, 66, 403-456
3. Qiu, A.; Jansen, M.; Sakaris, A.; Min, S. H.; Chattopadhyay, S.; Tsai, E.; Sandoval, C.; Zhao, R.; Akabas, M. H.; Goldman, I. D. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption Cell 2006, 127, 917-928
4. Wu, M.; Gunning, W.; Ratnam, M. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix Cancer Epidemiol. Biomarkers Prev. 1999, 8, 775-782
5. Parker, N.; Turk, M. J.; Westrick, E.; Lewis, J. D.; Low, P. S.; Leamon, C. P. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay Anal. Biochem. 2005, 338, 284-293
6. Low, P. S.; Kularatne, S. A. Folate-targeted therapeutic and imaging agents for cancer Curr. Opin. Chem. Biol. 2009, 13, 256-262
7. Leamon, C. P.; Low, P. S. Folate-mediated targeting: From diagnostics to drug and gene delivery Drug Discov ery Today 2001, 6, 44-51
8. Hilgenbrink, A. R.; Low, P. S. Folate receptor-mediated drug targeting: From therapeutics to diagnostics J. Pharm. Sci. 2005, 94, 2135-2146
9. Sega, E. I.; Low, P. S. Tumor detection using folate receptor-targeted imaging agents Cancer Metastasis Rev. 2008, 27, 655-664
10. Leamon, C. P.; Low, P. S. Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 5572-5576
11. Paulos, C. M.; Reddy, J. A.; Leamon, C. P.; Turk, M. J.; Low, P. S. Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery Mol. Pharmacol. 2004, 66, 1406-1414
12. Ke, C. Y.; Mathias, C. J.; Green, M. A. Folate-receptor-targeted radionuclide imaging agents Adv. Drug Delivery Rev. 2004, 56, 1143-1160
13. Muller, C.; Schibli, R. Folic acid conjugates for nuclear imaging of folate receptor-positive cancer J. Nucl. Med. 2011, 52, 1-4
14. Siegel, B. A.; Dehdashti, F.; Mutch, D. G.; Podoloff, D. A.; Wendt, R.; Sutton, G. P.; Burt, R. W.; Ellis, P. R.; Mathias, C. J.; Green, M. A.; Gershenson, D. M. Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results J. Nucl. Med. 2003, 44, 700-707
15. Fisher, R. E.; Siegel, B. A.; Edell, S. L.; Oyesiku, N. M.; Morgenstern, D. E.; Messmann, R. A.; Amato, R. J. Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors J. Nucl. Med. 2008, 49, 899-906
16. Symanowski, J. T.; A., M.; Naumann, R. W.; Shah, N. P.; Morgenstern, D; Messmann, R. A. use of 99mTc-EC20 (a folate-targeted imaging agent) to predict response to therapy with EC145 (folate-targeted therapy) in advanced ovarian cancer J. Clin. Oncol. 2010, 28
17. Fani, M.; Andre, J. P.; Maecke, H. R. 68Ga-PET: A powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals Contrast Media Mol. Imaging 2008, 3, 67-77
18. Roesch, F.; Riss, P. J. The renaissance of the Ge/Ga radionuclide generator initiates new developments in Ga radiopharmaceutical chemistry Curr. Top. Med. Chem. 2010, 10, 1633-1668
19. Fani, M.; Wang, X.; Nicolas, G.; Medina, C.; Raynal, I.; Port, M.; Maecke, H. R. Development of new folate-based PET radiotracers: Preclinical evaluation of Ga-DOTA-folate conjugates Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 108-119
20. Westerhof, G. R.; Schornagel, J. H.; Kathmann, I.; Jackman, A. L.; Rosowsky, A.; Forsch, R. A.; Hynes, J. B.; Boyle, F. T.; Peters, G. J.; Pinedo, H. M. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: Correlates of molecular-structure and biological activity Mol. Pharmacol. 1995, 48, 459-471
21. Antony, A. C.; Kane, M. A.; Portillo, R. M.; Elwood, P. C.; Kolhouse, J. F. Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells J. Biol. Chem. 1985, 260, 14911-14917
22. McHugh, M.; Cheng, Y. C. Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells J. Biol. Chem. 1979, 254, 11312-11318
23. Muller, C.; Schibli, R.; Krenning, E. P.; de Jong, M. Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer J. Nucl. Med. 2008, 49, 623-629
24. Muller, C.; Reddy, J. A.; Leamon, C. P.; Schibli, R. Effects of the antifolates pemetrexed and CB3717 on the tissue distribution of (99m)Tc-EC20 in xenografted and syngeneic tumor-bearing mice Mol. Pharmaceutics 2010, 7, 597-604
25. Luo, J.; Smith, M. D.; Lantrip, D. A.; Wang, S; Fuchs, P. L. Efficient Syntheses of Pyrofolic Acid and Pteroyl Azide, Reagents for the Production of Carboxyl-Differentiated Derivatives of Folic Acid J. Am. Chem. Soc. 1997, 119, 10004-10013
26. Port, M.; Medina, C. Use of buffers for the complexation of radionuclides. Patent FR 2942227 A1 20100820, 2010.
27. Zhernosekov, K. P.; Filosofov, D. V.; Baum, R. P.; Aschoff, P.; Bihl, H.; Razbash, A. A.; Jahn, M.; Jennewein, M.; Rosch, F. Processing of generator-produced 68Ga for medical application J. Nucl. Med. 2007, 48, 1741-1748
28. Muller, C.; Vlahov, I. R.; Santhapuram, H. K.; Leamon, C. P.; Schibli, R. Tumor targeting using (67)Ga-DOTA-Bz-folate-investigations of methods to improve the tissue distribution of radiofolates Nucl. Med. Biol. 2011, 38, 715-723
29. Mathias, C. J.; Wang, S.; Lee, R. J.; Waters, D. J.; Low, P. S.; Green, M. A. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate J. Nucl. Med. 1996, 37, 1003-1008
30. Fields, M. M.; Chevlen, E. Ovarian cancer screening: a look at the evidence Clin. J. Oncol. Nurs. 2006, 10, 77-81
31. Muller, C.; Mindt, T. L.; de Jong, M.; Schibli, R. Evaluation of a novel radiofolate in tumour-bearing mice: Promising prospects for folate-based radionuclide therapy Eur. J. Nucl. Med. Mol. Imaging 2009, 36, 938-946
32. Mathias, C. J.; Lewis, M. R.; Reichert, D. E.; Laforest, R.; Sharp, T. L.; Lewis, J. S.; Yang, Z. F.; Waters, D. J.; Snyder, P. W.; Low, P. S.; Welch, M. J.; Green, M. A. Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine- folate as potential folate-receptor-targeted PET radiopharmaceuticals Nucl. Med. Biol. 2003, 30, 725-731
33. Bettio, A.; Honer, M.; Muller, C.; Bruhlmeier, M.; Muller, U.; Schibli, R.; Groehn, V.; Schubiger, A. P.; Ametamey, S. M. Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors J. Nucl. Med. 2006, 47, 1153-1160
34. Ross, T. L.; Honer, M.; Lam, P. Y.; Mindt, T. L.; Groehn, V.; Schibli, R.; Schubiger, P. A.; Ametamey, S. M. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative Bioconjugate Chem. 2008, 19, 2462-2470
35. Mindt, T. L.; Muller, C.; Stuker, F.; Salazar, J. F.; Hohn, A.; Mueggler, T.; Rudin, M.; Schibli, R. A "click chemistry" approach to the efficient synthesis of multiple imaging probes derived from a single precursor Bioconjugate Chem. 2009, 20, 1940-1949
36. Ross, T. L.; Honer, M.; Muller, C.; Groehn, V.; Schibli, R.; Ametamey, S. M. A new 18F-labeled folic acid derivative with improved properties for the PET imaging of folate receptor-positive tumors J. Nucl. Med. 2010, 51, 1756-1762
37. Mathias, C. J.; Wang, S.; Low, P. S.; Waters, D. J.; Green, M. A. Receptor-mediated targeting of 67Ga-deferoxamine-folate to folate-receptor- positive human KB tumor xenografts Nucl. Med. Biol. 1999, 26, 23-25
38. Caraco, C.; Aloj, L.; Eckelman, W. C. The gallium-deferoxamine complex: Stability with different deferoxamine concentrations and incubation conditions Appl. Radiat. Isot. 1998, 49, 1477-1479